 |
|
 |
 |

Home > Company Index > Drugs > Vitamins, Nutritional & Other Health Related Products > Akorn, Inc.
 |
Akorn, Inc. |
 |
 |
 |
PROFILE |
 |
At Akorn, the eyes have it. The company's ophthalmic unit produces anesthetic and diagnostic products, as well as antibiotics, steroids, glaucoma treatments, and surgical and eye care products. Its injectable unit makes generic drugs and anesthetics for arthritis and pain management. Akorn provides contract manufacturing services to other drug and biotech firms; it also markets its own ophthalmic and injectable products, which are sold to physicians, optometrists, wholesalers, retailers, and pharmacies. Chairman John Kapoor owns more than 20% of the company, whose sales are split evenly between the units.
COMPETITION |
 |
Alcon Laboratories, Inc. (dossier)
Allergan, Inc. (AGN)
Bausch & Lomb Incorporated (BOL)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 66.90
1-Yr. Sales Growth: 3.6%
Employees: 447
Revenue per employee: $149,664.43
KEY PEOPLE |
 |
John N. Kapoor
CEO
Kevin M. Harris
CFO
CONTACT INFO |
 |
2500 Millbrook Dr.
Buffalo Grove, IL 60089
US
Phone: 847-279-6100
Fax: 800-943-3694
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |